The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.

Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

An essay by Vas Narasimhan, CEO of Novartis about the historical context and coming innovations in medicine with an introduction by Goran Mijuk.

At Novartis, we celebrate life and recognize moments that matter. Alfred Ambatlle shares his experience of parental leave and becoming a father of twins.